Skip to the page

Data / Form D filings / INIA Biosciences, Inc.

INIA Biosciences, Inc.: Form D filing

INIA Biosciences, Inc., a company in Boston, MA, filed a Form D with the SEC in 2024. The latest, on September 25, 2024, reports $200,000 sold of a $3 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
100 Morrissey Blvd, Boston, MA, 02125
Phone
(916) 600-0218
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2038627

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 25, 2024New notice$3,000,000$200,000$2,800,0002Nov 25, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dragana SavicExecutive Officer, Director
Michael HoganExecutive Officer, Director
Shen NingExecutive Officer, Director

Other companies in Massachusetts that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what INIA Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.